Volume 28, Number 1—January 2022
CME ACTIVITY - Synopsis
Using the Acute Flaccid Paralysis Surveillance System to Identify Cases of Acute Flaccid Myelitis, Australia, 2000‒2018
Table 1
Characteristic |
Value |
Sex | |
M | 19 (46.3) |
F |
22 (53.7) |
Median age, y, at onset (range) |
4.07 (0.25–14.08) |
Prodromal illness | |
Confirmed | 6 (14.6) |
Probable | 15 (36.6) |
No | 13 (31.7) |
Unknown |
7 (17.1) |
Confirmed specified | |
URTI | 5 (83.3) |
Gastrointestinal |
1 (16.7) |
Site of paralysis | |
Known | 39 (95.1) |
Unknown |
2 (4.9) |
Site of paralysis, upper limbs | |
Unilateral | 11 (28.2) |
Bilateral |
3 (7.7) |
Site of paralysis, lower limbs | |
Unilateral | 3 (7.7) |
Bilateral |
13 (33.3) |
Site of paralysis, upper and lower limbs | |
Unilateral | 5 (12.8) |
Bilateral |
4 (10.3) |
Bulbar/cranial nerve palsy | |
Yes | 14 (34.1) |
No | 26 (63.4) |
Unknown |
1 (2.4) |
Reduced sensation | |
Yes | 6 (14.6) |
No | 34 (82.9) |
Unknown |
1 (2.4) |
Bladder/bowel dysfunction | |
Yes | 17 (41.5) |
No | 15 (36.5) |
Unknown |
9 (22.0) |
Median CSF protein level, g/L (range) |
0.43 (0.11–1.18) |
Elevated CSF protein level >0.55 g/L | |
Yes | 8 (19.5) |
No | 29 (70.7) |
Unknown |
4 (9.8) |
Median CSF leukocyte count/mm3 (range) |
38 (0–267) |
Pleocytosis >5 cells mm3 | |
Yes | 33 (80.5) |
No | 3 (7.3) |
Unknown | 5 (12.2) |
*Values are no. (%) unless otherwise indicated. CSF, cerebrospinal fluid; URTI, upper respiratory tract infection.
1Members of this panel are listed at the end of this article.
Page created: October 08, 2021
Page updated: December 16, 2021
Page reviewed: December 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.